Christopher James O'Callaghan
Queen's University · 193 works · 13,254 citations · h-index 43
Top works
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials
- Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer
- Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections
- Family satisfaction with care in the intensive care unit: Results of a multiple center study*
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- Decision-making in the ICU: perspectives of the substitute decision-maker
- End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group
- Dying in the ICU
- Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr
- Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
- Climate change and the potential for range expansion of the Lyme disease vector Ixodes scapularis in Canada
- Mechanical Strain–Induced Extracellular Matrix Production by Human Vascular Smooth Muscle Cells
- A dynamic population model to investigate effects of climate on geographic range and seasonality of the tick Ixodes scapularis
- The seriously ill hospitalized patient: Preferred role in end-of-life decision making?
- Role of Migratory Birds in Introduction and Range Expansion of Ixodes scapularis Ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada
- Description of smallholder dairy farms in Kiambu District, Kenya
- Risk maps for range expansion of the Lyme disease vector, Ixodes scapularis, in Canada now and with climate change
- Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial